DDL Unveils State-of-the-Art GMP Laboratory to Strengthen Drug Delivery Testing Services

DDL Unveils New GMP Laboratory for Testing Drug-Delivery Systems

DDL, a prominent name in packag- ing, product, and material testing services, has announced an exciting expansion with the opening of a new Good Manufacturing Practice (GMP) lab. Situated in Eden Prairie, Minnesota, this facility marks a significant enhancement in DDL's capability to offer rigorous testing for drug-device combination products, addressing the evolving demands of the pharmaceuticals and biotechnology sectors.

A Comprehensive Lab Dedicated to Quality Testing

The new GMP laboratory spans an impressive 10,600 square feet and has received FDA registration. It is set to provide several crucial testing services including ICH stability testing and intricate functional and mechanical performance evaluations in accordance with ISO standards (ISO 11040, ISO 11608). Additionally, it will simulate distribution testing tailored to meet the needs of various combination products, such as auto-injectors, pre-filled syringes, and inhalers.

Equipped with cutting-edge technology and staffed by a team of experienced engineers and scientists, the lab is designed to meet global regulatory expectations. This strategic initiative allows DDL to grow its portfolio and extend its reach within the medical device and pharmaceutical industries.

Addressing Industry Demands

The expansion of the GMP lab is driven by the rising demand for high-quality testing solutions in the market. As John Koch, General Manager of DDL, pointed out, the market for combination products has been experiencing steady growth. The new lab will help ensure that manufacturers are equipped with the necessary resources and expertise to bring safe and effective products to the market efficiently.

Aaron Liss, DDL's Director of Sales and Marketing, expressed enthusiasm about the new facility, stating, "We are excited to expand our testing footprint with this new GMP laboratory, reinforcing our commitment to providing high-quality, reliable testing services to our medical device and pharmaceutical clients." Liss emphasizes that this development builds upon DDL's 35 years of experience in the industry, allowing them to collaborate more effectively with healthcare providers.

Ensuring Excellence in Testing Services

DDL's continuous investment in this GMP laboratory underscores its unwavering commitment to excellence within the testing sector of the life sciences industry. By maintaining a focused approach toward delivering precise and regulatory-compliant results, DDL supports clients throughout their product development and regulatory submission processes.

To showcase its advances in testing capabilities, DDL will be participating in the upcoming INTERPHEX conference from April 1-3, 2025, at the Javits Center in New York City. Attendees can visit DDL at Booth #1143 to learn more about their GMP testing offerings, as well as their broader suite of package, medical device, and material testing services.

For further inquiries about DDL's comprehensive testing solutions or for quotes, potential clients can contact them at info@DDLTesting.com or call directly at 800-229-4235.

About DDL

DDL operates as an independent third-party testing company, primarily serving the life sciences sector by providing expertise in medical devices, materials, and packaging testing. With laboratories located in Eden Prairie, Minnesota, Irvine, California, and Edison, New Jersey, DDL aims to ensure that its clients receive top-notch service and support throughout their testing needs. For more information about DDL’s testing services and capabilities, visit www.DDLTesting.com.

This new GMP laboratory opens a new chapter for DDL as it continues to support the pharmaceutical and biotechnology communities in their mission to develop safe and effective medical products.